tradingkey.logo

Aardvark Therapeutics Inc

AARD
14.550USD
0.0000.00%
Close 12/22, 16:00ETQuotes delayed by 15 min
316.39MMarket Cap
LossP/E TTM
You can access the annual and quarterly cash flow statements of Aardvark Therapeutics Inc to evaluate its financial soundness and stability.
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
Operating cash flows (indirect method)
Cash flow from continuing operating activities
-307.84%-16.13M
-133.55%-9.84M
-420.00%-11.39M
-568.43%-7.73M
-149.53%-3.96M
---4.21M
---2.19M
---1.16M
---1.58M
Net income from continuing operations
-290.15%-16.32M
-163.66%-14.37M
-327.46%-9.31M
-330.13%-8.78M
-98.29%-4.18M
---5.45M
---2.18M
---2.04M
---2.11M
Operating gains losses
25.00%10.00K
--11.00K
150.00%5.00K
-68.00%8.00K
-69.23%8.00K
----
--2.00K
--25.00K
--26.00K
Other non-cash items
-465.82%-289.00K
-1489.19%-514.00K
-79.69%26.00K
-94.90%10.00K
-67.49%79.00K
--37.00K
--128.00K
--196.00K
--243.00K
Change in working capital
-940.63%-999.00K
273.83%4.38M
-638.87%-2.36M
17.44%815.00K
69.62%-96.00K
--1.17M
---319.00K
--694.00K
---316.00K
-Change in prepaid expenses
-616.93%-1.31M
275.00%84.00K
-1213.86%-4.36M
-15.32%-286.00K
271.62%254.00K
---48.00K
---332.00K
---248.00K
---148.00K
Cash from non-recurring investing activities
Cash from operating activities
-307.84%-16.13M
-133.55%-9.84M
-420.00%-11.39M
-568.43%-7.73M
-149.53%-3.96M
---4.21M
---2.19M
---1.16M
---1.58M
Investing cash flow
Net cash from continuing investing activities
-20.00%4.00K
-2.15%91.00K
-100.00%0.00
--6.00K
--5.00K
--93.00K
--5.00K
----
--0.00
Capital expenditures
-20.00%4.00K
-2.15%91.00K
-100.00%0.00
--6.00K
--5.00K
--93.00K
--5.00K
----
--0.00
Net cash flow from disposal of fixed assets
-20.00%4.00K
-2.15%91.00K
-100.00%0.00
--6.00K
--5.00K
--93.00K
--5.00K
----
--0.00
Net cash flow from investment products
--29.25M
--9.50M
---112.62M
---11.89M
----
----
--0.00
----
----
Net cash flow from other investing activities
--0.00
----
----
----
----
----
----
----
----
Cash from non-current investing activities
Net cash flow from investing activities
585020.00%29.25M
10217.20%9.41M
-2252380.00%-112.62M
---11.89M
---5.00K
---93.00K
---5.00K
--0.00
--0.00
Financing cash flow
Cash flow from continuous financing activities
167.19%171.00K
-100.09%-71.00K
--88.88M
---1.01M
--64.00K
--82.94M
--0.00
--0.00
--0.00
Net cash flow from common stock issuance/repurchase
--0.00
--0.00
--91.08M
----
----
----
--0.00
----
----
Net cash flow from preferred stock issuance/repurchase
--0.00
----
----
--0.00
--0.00
--85.00M
----
----
--0.00
Proceeds from stock option exercised by employees
1.18%171.00K
--6.00K
--110.00K
--163.00K
--169.00K
----
--0.00
--0.00
----
Net cash flow from other financing activities
100.00%0.00
96.26%-77.00K
---2.31M
---1.18M
---105.00K
---2.06M
--0.00
----
--0.00
Net cash from non-recurrent financing activities
Net cash from financing activities
167.19%171.00K
-100.09%-71.00K
--88.88M
---1.01M
--64.00K
--82.94M
--0.00
--0.00
--0.00
Net cash flow
Beginning cash balance
-69.83%26.00M
251.51%26.50M
533.19%61.64M
655.46%82.28M
590.71%86.17M
--7.54M
--9.73M
--10.89M
--12.48M
Current period cash flow changes
441.04%13.29M
-100.64%-506.00K
-1500.77%-35.14M
-1685.12%-20.64M
-145.80%-3.90M
--78.63M
---2.19M
---1.16M
---1.58M
Ending cash balance
-52.25%39.28M
-69.83%26.00M
251.51%26.50M
533.19%61.64M
655.46%82.28M
--86.17M
--7.54M
--9.73M
--10.89M
Free cash flow
-307.42%-16.13M
-130.62%-9.94M
-418.82%-11.39M
---7.73M
-149.84%-3.96M
---4.31M
---2.19M
----
---1.58M
Currency unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit opinions
--
--
--
--
--
--
--
--
--

FAQs

What is the cash flow statement?

This report tracks the movement of cash into and out of the business, covering operating, investing, and financing activities. It highlights how well the company manages cash to support growth and meet its obligations.
KeyAI